Interchange Capital Partners LLC Sells 3,274 Shares of HCA Healthcare, Inc. $HCA

Interchange Capital Partners LLC decreased its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 91.7% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 297 shares of the company’s stock after selling 3,274 shares during the quarter. Interchange Capital Partners LLC’s holdings in HCA Healthcare were worth $114,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in the company. Price T Rowe Associates Inc. MD increased its stake in shares of HCA Healthcare by 83.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company’s stock valued at $829,104,000 after acquiring an additional 1,091,416 shares in the last quarter. Goldman Sachs Group Inc. increased its stake in shares of HCA Healthcare by 49.1% in the 1st quarter. Goldman Sachs Group Inc. now owns 1,781,459 shares of the company’s stock valued at $615,583,000 after acquiring an additional 587,036 shares in the last quarter. Nuveen LLC bought a new stake in shares of HCA Healthcare in the 1st quarter valued at $569,217,000. Pacer Advisors Inc. increased its stake in HCA Healthcare by 6,237.9% during the 1st quarter. Pacer Advisors Inc. now owns 1,350,933 shares of the company’s stock valued at $466,815,000 after purchasing an additional 1,329,618 shares in the last quarter. Finally, Principal Financial Group Inc. increased its stake in HCA Healthcare by 0.8% during the 1st quarter. Principal Financial Group Inc. now owns 880,663 shares of the company’s stock valued at $304,313,000 after purchasing an additional 6,888 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have commented on HCA. Cantor Fitzgerald restated an “overweight” rating and set a $444.00 price target on shares of HCA Healthcare in a research note on Tuesday, October 7th. Morgan Stanley decreased their price target on shares of HCA Healthcare from $410.00 to $400.00 and set an “equal weight” rating for the company in a research note on Monday, July 28th. Bank of America lifted their price objective on shares of HCA Healthcare from $375.00 to $410.00 and gave the stock a “neutral” rating in a report on Wednesday, September 10th. Wall Street Zen raised shares of HCA Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, July 5th. Finally, The Goldman Sachs Group assumed coverage on shares of HCA Healthcare in a report on Tuesday. They set a “buy” rating and a $470.00 price objective on the stock. One equities research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and nine have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $431.07.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the company’s stock in a transaction that occurred on Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the sale, the executive vice president owned 31,503 shares of the company’s stock, valued at $13,194,716.52. This represents a 10.85% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 1.30% of the company’s stock.

HCA Healthcare Stock Performance

Shares of HCA Healthcare stock opened at $418.34 on Wednesday. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $439.01. The stock’s 50-day simple moving average is $407.16 and its 200 day simple moving average is $376.85. The stock has a market capitalization of $97.89 billion, a P/E ratio of 17.58, a P/E/G ratio of 1.29 and a beta of 1.40.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, beating the consensus estimate of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The firm had revenue of $18.61 billion for the quarter, compared to analysts’ expectations of $18.49 billion. During the same period in the prior year, the business posted $5.50 earnings per share. The company’s revenue was up 6.4% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. Equities research analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th were given a $0.72 dividend. This represents a $2.88 annualized dividend and a dividend yield of 0.7%. The ex-dividend date was Tuesday, September 16th. HCA Healthcare’s dividend payout ratio is 12.11%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.